Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Intech Albuterol Sulfate HFA vs ProAir HFA in Mild Asthma
NCT04912596Recruiting
- Sponsor
- Intech Biopharm Corporation
- Start
- Aug 2022
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Randomised, double-blind trial of salbutamol in asthma (4 arms), sponsored by Intech Biopharm Corporation. Primary endpoint: Post-dose PC20 Concentration. Started Aug 2022; status: recruiting.
02
Drugs
salbutamol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04912596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04912596.